Key pathway to stop dangerous, out-of-control inflammation discovered

April 9, 2013

A potential new strategy to developing new drugs to control inflammation without serious side effects has been found by Georgia State University researchers and international colleagues.

Jian-Dong Li, director of Georgia State's Center for Inflammation, Immunity and Infection, and his team discovered that blocking a certain pathway involved in the of inflammation will suppress it.

Inhibiting a molecule called phosphodiesterase 4B, or PDE4B, suppresses inflammation by affecting a key gene called CLYD, a gene that serves as a brake on inflammation.

The research was published in the journal Nature Communications.

Li explained the process of overactive inflammation using a "police" analogy.

When a pathogen – such as bacteria or viruses—infects a patient, he said, it triggers an "alarm" to which the "police" of immune system respond. In turn, it triggers neutrophil attractant called cytokines to respond, leading to inflammation that serves to help rid the body of the pathogen. But if inflammation isn't stopped, can result.

The pathways during the response are termed "positive," like a gas pedal on a car, and "negative," like a brake, with the process in the positive pathway going down the line from the pathogen to inflammation, and negative going the other direction. PDE4B is involved in controlling the negative pathway.

Many researchers have been focusing on developing anti- by stopping the positive pathway, but the discovery by Li and his colleagues gives scientists a new route to stop inflammation using safer or even existing drugs proven to be non-toxic as they have found that accelerating the negative will reduce inflammation.

"This is the key negative regulator that we have been searching after for years, " Li said.

There is a need for better drugs to control inflammation, because current treatments come with serious side effects, Li said. Steroids are commonly used, but cannot be used over the long-term. Steroids suppress the immune system.

Explore further: Researchers find critical regulator to tightly control deadly pulmonary fibrosis

More information: The article is "Inhibition of PDE4B suppresses inflammation by increasing expression of the deubiquitinase CLYD," in Nature Communications, available at hx.doi.org/10.1038/ncomms6274

Related Stories

New drug target found for cystic fibrosis lung disease

November 7, 2012

Vancouver researchers have discovered the cellular pathway that causes lung-damaging inflammation in cystic fibrosis (CF), and that reducing the pathway's activity also decreases inflammation. The finding offers a potential ...

Recommended for you

Scientists reveal cellular clockwork underlying inflammation

August 27, 2015

Researchers at the Virginia Bioinformatics Institute at Virginia Tech have uncovered key cellular functions that help regulate inflammation—a discovery that could have important implications for the treatment of allergies, ...

New research finds ozone in smog may cause asthma

September 7, 2015

It's completely invisible, but the distinctive smell of electrical discharge after photocopying is a tell-tale sign of ozone in the air. Ozone is a component of what we refer to as 'smog' and on hot sunny days, in cities ...

Severe asthma fails to respond to mainstay treatment

June 29, 2015

The immune response that occurs in patients with severe asthma is markedly different than what occurs in milder forms of the lung condition, according to researchers from the University of Pittsburgh School of Medicine. Those ...

New hope for patients with chronic wounds

June 29, 2015

Most wounds clear up by themselves, but some fail to heal and become chronic. An international team of researchers led from Karolinska Institutet, now unveil the important role of so-called microRNAs in regulating skin wound ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.